News and Media
Bioplatforms Australia is committed to providing the research infrastructure required and fostering the collaboration of the best brains in genomic research to achieve life-changing beneficial outcomes for people suffering from cancer or rare diseases.
Bioplatforms Australia is a signatory to a Memorandum of Understanding between researchers in the USA and Australia, announced by US Vice-President Joe Biden. The MoU will facilitate the sharing of an unprecedented international dataset which will significantly advance cancer research and care.
Bioplatforms Australia through the Commonwealth Government NCRIS programme has committed $500,000 for an infrastructure project to develop a large framework ‘omic dataset for corals and their associated Symbiodinium and microbes.
A $2 million dollar grant and co-investment will facilitate the acquisition of crucial next-generation genomics infrastructure. Tangible contributions to the value of $7.3 million will provide the capital and operational budget for this infrastructure.
Bioplatforms Australia has instigated a pioneering investigation into the life-sustaining microbes that inhabit our oceans and their potential as an indicator of marine life health.
Message from Bioplatforms Australia’s new Chairman – Dr Les Trudzik, New Biophotonics Centre of Excellence, ANU builds genomics resources for biodiversity studies, Australia to lead the way in innovative sleep research, Six years and still growing, New capabilities in metabolite analysis.
Bioplatforms Australia partnership with the Garvan Institute expands access to breakthrough genomics capability. Research infrastructure organisation, Bioplatforms Australia, has announced a strategic partnership with the Garvan Institute of Medical Research that will expand researcher access to the most powerful high-throughput sequencing platform presently available in the world.
New dataset supports great barrier reef, personalised cancer vaccines, Geraniums offer new insights on genetic evolution, Genomics virtual laboratory, the challenges of big data, Metabolomics in biomarker discovery, 2012 annual report.
+61 0410 538 648